Close
Close

Published

Amiko hints at scale of IoT-based medical compliance market

IoT-based medical adherence is likely to become a major field, and there are already signs it is taking off in some areas, one being around inhalers for respiratory conditions. especially asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF). This has attracted a cluster of start-ups, with London-based Amiko emerging as one of the most successful outside the US. Medical non-compliance is a major cause of health problems and below par treatment outcomes. The biggest study so far has been conducted in the US by the National Institutes of Health (NIH), finding that between $100bn and $300bn of avoidable health care costs result from nonadherence in the US annually, equating to between 3% and 10% of the country’s total…

Close